0.10Open0.10Pre Close0 Volume39 Open Interest22.50Strike Price0.00Turnover70.70%IV29.36%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.0801Delta0.0506Gamma174.70Leverage Ratio-0.0106Theta0.0007Rho13.99Eff Leverage0.0062Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet